Lantern has successfully confirmed PTGR1 as a key biomarker that it intends to use to optimize patient selection based on potential tumor sensitivity to the drug candidate LP-184. LP-184 is a ...

Add Yahoo as a preferred source to see more of our stories on Google. Babies are curious about their world and want to explore. Jose Luis Pelaez Inc/DigitalVision via Getty Images Infant milestones ...

Prescreening rate of Phase 2b ReTain trial triggers clinical development milestone payment in September Potentially registrational trial is targeting enrollment of approximately 500 participants with ...

ROCKVILLE, Md., Oct. 10, 2024 /PRNewswire/ -- Expert Systems, a leader in combining human and artificial intelligence to accelerate drug discovery, celebrates a key milestone in the development of ...

Nearly one in four parents express concern about their child not meeting developmental milestones. Michael A. Traub, MD, a primary care provider at Crystal Run Healthcare who is board certified in ...

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has earned a $200 million milestone payment from Sarepta Therapeutics (NASDAQ: SRPT). The ...